T1	Pharmacological_substance 9 22	Carbamazepine
N1000 	Reference T1 MeSH:D002220	Carbamazepine
T2	Disorder 31 72	systemic lupus erythematosus-like disease
T3	Disorder 106 134;140 154	systemic lupus erythematosus -like symptoms
T4	Disorder 136 139	SLE
N1 	Reference T4 UMLS:C0024141	SLE
N2 	Reference T4 UMLS:C0014060	SLE
N3 	Reference T4 UMLS:C0024141	SLE
T5	Disorder 156 160	rash
N4 	Reference T5 UMLS:C0015230	rash
T6	Disorder 162 167	fever
N5 	Reference T6 UMLS:C0015967	fever
T7	Disorder 169 179	leukopenia
N6 	Reference T7 UMLS:C0023530	leukopenia
T8	Pharmacological_substance 255 268	carbamazepine
N1001 	Reference T8 MeSH:D002220	carbamazepine
T9	Pharmacological_substance 270 273	CBZ
N1002 	Reference T9 MeSH:D002220	CBZ
T10	Pharmacological_substance 275 283	Tegretol
N1003 	Reference T10 MeSH:D002220	Tegretol
T11	Disorder 298 322	benign Rolandic epilepsy
N7 	Reference T11 UMLS:C2363129	benign Rolandic epilepsy
T12	Disorder 346 356	leukopenia
N8 	Reference T12 UMLS:C0023530	leukopenia
T13	Pharmacological_substance 393 396	CBZ
N1004 	Reference T13 MeSH:D002220	CBZ
T14	Pharmacological_substance 419 431	prednisolone
N1005 	Reference T14 MeSH:D011239	prednisolone
T16	Pharmacological_substance 455 458	CBZ
N1006 	Reference T16 MeSH:D002220	CBZ
T17	Disorder 467 470	SLE
N9 	Reference T17 UMLS:C0024141	SLE
N10 	Reference T17 UMLS:C0014060	SLE
N11 	Reference T17 UMLS:C0024141	SLE
T18	Subject 75 95	A 14-year-old female
T22	Disorder 184 214	positive anti-nuclear antibody
T23	Disorder 216 219	ANA
N12 	Reference T23 UMLS:C0393778	ANA
N13 	Reference T23 UMLS:C0175713	ANA
N14 	Reference T23 UMLS:C1862382	ANA
T26	Disorder 324 341	Clinical symptoms
N15 	Reference T26 UMLS:C1457887	Clinical symptoms
